美国体外反搏 (ECP) 设备市场规模、份额和趋势分析报告：按产品、最终用途和细分市场预测，2023-2030 年

美国体外反搏 (ECP) 设备市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，到 2030 年，美国体外反搏（ECP）设备市场规模预计将达到 2.725 亿美元，预测期内年复合成长率为 7.6%。

心血管疾病患病的增加和对有效治疗的需求推动了成长。 ECP 疗法以其非侵入性性和在治疗心绞痛和心臟衰竭等疾病方面已被证明的有效性而闻名，并引起了患者和医疗保健提供者的极大兴趣。

冠状动脉疾病患病的上升、冠状动脉患者动脉粥状硬化的增加以及心绞痛发作的急剧增加预计将推动外部脉动装置市场的成长。由于比例患有心绞痛领先患有冠状动脉疾病的患者以及越来越多地采用 ECP 设备来治疗心绞痛，预计该市场将会成长。 40岁以上患者动脉粥状硬化的高发生率进一步增加了对ECP治疗的需求，因为这个年龄组中近50%的人可能会出现严重的动脉粥样硬化。我是。

由于该行业的技术突破和创新，体外反搏 (ECP) 设备市场正在显着成长。透过添加先进的监控功能、客製化选项和电子健康记录系统整合，製造商不断增强 ECP 设备，以改善患者护理、安全和结果。积极的报销政策和法律规范正在促进ECP设备在诊所和医院的使用，推动了市场的上升趋势。此外，市场上的大量竞争以及 FDA 对治疗多种心臟疾病的批准预计将推动全球 ECP 设备市场的扩张。

美国体外反搏 (ECP) 设备市场报告亮点

• 2022年，气动ECP装置领域占据压倒性的市场占有率，达35.68%。这些装置利用气压来改善流向心臟的血液，有效缓解心绞痛或难治性心绞痛患者的症状。其非侵入性、成本效益和持续的技术进步使其对患者和医疗保健提供者俱有吸引力。心血管疾病患病的上升进一步推动了这一领域的成长，使其成为心臟病患者有希望的治疗选择。
• 2022年，医院主导ECP设备市场，占有率为35.68%。该医院庞大的患者量、心血管疾病的专业治疗、先进的资源和技术以及全面的治疗方案使其成为ECP治疗的首选。心血管疾病呈上升趋势，医院ECP设备的需求预计将进一步增强市场主导地位。
• 主要市场参与企业包括 Vaso Corporation、ACS Diagnostics、Scottcare Corporation 和 Cardiomedics Inc.。

目录

第1章调查方法和范围

第2章执行摘要

第3章市场变数、趋势和范围

• 市场区隔和范围
• 市场体系预测
  • 母市场预测
  • 相关/附随市场预测
• 市场趋势及展望
• 市场动态
• 市场抑制因素分析
• 2022 年普及与成长前景预测
• 营商环境分析
  • SWOT 分析；要素因素（政治/法律、经济/技术）
  • 波特五力分析
• COVID-19感染疾病的影响分析

第4章美国体外反搏（ECP）设备市场：产品細項分析

• 美国体外反搏 (ECP) 设备市场：2022 年和 2030 年市场占有率分析
• 气动ECP装置
• 心电图 (ECG) 同步 ECP 装置
• 扩展体外反搏 (EECP) 装置

第5章美国体外反搏（ECP）设备市场：最终用途細項分析

• 美国体外反搏 (ECP) 设备：2022 年和 2030 年市场占有率分析
• 心臟中心
• 医院

第6章竞争形势

• 公司分类
• 策略规划
• 2022 年公司市场占有率分析
• 公司简介/名单
  • Vaso Corporation
  • ACS Diagnostics
  • Scottcare Corporation
  • Cardiomedics Inc

U.S. External Counterpulsation (ECP) Devices Market Growth & Trends:

The U.S. external counterpulsation (ECP) devices market size is expected to reach USD 272.5 million by 2030, growing at a CAGR of 7.6% during the forecast period, according to a new report by Grand View Research, Inc.. The growth is driven by the increasing prevalence of cardiovascular diseases and the demand for effective treatments. ECP therapy, known for its non-invasive nature and proven efficacy in managing conditions like angina pectoris and heart failure, has garnered significant interest from patients and healthcare providers.

The rise in the prevalence of coronary artery diseases, increase in atherosclerosis in coronary artery patients, and surge in angina episodes are projected to drive the external counterpulsation devices market's growth. With a significant proportion of coronary artery disease cases preceding angina and the rising adoption of ECP devices for managing angina, the market is expected to grow. The incidence of atherosclerosis, most common in patients above 40, further contributes to the demand for ECP therapy, as nearly 50% of individuals in this age group are likely to develop serious atherosclerosis conditions.

Significant growth has been seen in the market for external counterpulsation (ECP) devices, driven by technological breakthroughs and innovations in the industry. By adding advanced monitoring capabilities, customization choices, and electronic medical record system integration, manufacturers continuously enhance ECP devices, improving patient care, safety, and treatment outcomes. Positive reimbursement policies and regulatory frameworks promote the growing use of ECP devices in clinic and hospital settings, which adds to the market's upward trend. Additionally, significant competitors in the market and FDA clearance for treating several cardiac diseases are anticipated to fuel the expansion of the worldwide ECP devices market.

U.S. External Counterpulsation Devices Market Report Highlights:

• In 2022, the pneumatic ECP devices segment held a dominant market share of 35.68%. These devices use air pressure to improve blood flow to the heart, effectively reducing symptoms in angina and refractory angina pectoris patients. Their non-invasive nature, cost-effectiveness, and ongoing technological advancements make them appealing to patients and healthcare providers. The rising prevalence of cardiovascular diseases further fuels the growth of this segment, making it a promising therapeutic option for cardiac patients
• In 2022, hospitals dominated the ECP device market with a share of 35.68%. Their larger patient volumes, specialized care for cardiovascular diseases, access to advanced resources and technologies, and comprehensive treatment options make hospitals the preferred choice for ECP therapy. As cardiovascular diseases continue to rise, the demand for hospital ECP devices is expected to reinforce their market dominance
• Some key market players are Vaso Corporation, ACS Diagnostics, Scottcare Corporation, and Cardiomedics Inc.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Information Procurement
• 1.2. Information Or Data Analysis
• 1.3. Market Scope & Segment Definition
• 1.4. Market Model

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Dynamics
• 3.5. Market Restraint Analysis
• 3.6. Penetration And Growth Prospect Mapping 2022
• 3.7. Business Environment Analysis
  • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
  • 3.7.2. Porter's Five Forces Analysis
• 3.8. COVID-19 Impact Analysis

Chapter 4. U.S. External Counterpulsation (ECP) Devices Market: Product Segment Analysis

• 4.1. U.S. External Counterpulsation (ECP) Devices Market: Market Share Analysis, 2022 & 2030
• 4.2. Pneumatic ECP Devices
  • 4.2.1. Pneumatic ECP Devices Market, 2018 - 2030 (USD Million)
• 4.3. Electrocardiogram (ECG)-Synchronized ECP Devices
  • 4.3.1. Electrocardiogram (ECG)-Synchronized ECP Devices Market, 2018 - 2030 (USD Million)
• 4.4. Enhanced External Counterpulsation (EECP) Devices
  • 4.4.1. Enhanced External Counterpulsation (EECP) Devices Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. External Counterpulsation (ECP) Devices Market: End-Use Segment Analysis

• 5.1. U.S. External Counterpulsation (ECP) Devices: Market Share Analysis, 2022 & 2030
• 5.2. Cardiac Centers
  • 5.2.1. Cardiac Centers Market, 2018 - 2030 (USD Million)
• 5.3. Hospitals
  • 5.3.1. Hospitals Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company Categorization
• 6.2. Strategy Mapping
• 6.3. Company Market Share Analysis, 2022
• 6.4. Company Profiles/Listing
  • 6.4.1. Vaso Corporation
    • 6.4.1.1. Overview
    • 6.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 6.4.1.3. Product Benchmarking
    • 6.4.1.4. Strategic Initiatives
  • 6.4.2. ACS Diagnostics
    • 6.4.2.1. Overview
    • 6.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 6.4.2.3. Product Benchmarking
    • 6.4.2.4. Strategic Initiatives
  • 6.4.3. Scottcare Corporation
    • 6.4.3.1. Overview
    • 6.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 6.4.3.3. Product Benchmarking
    • 6.4.3.4. Strategic Initiatives
  • 6.4.4. Cardiomedics Inc
    • 6.4.4.1. Overview
    • 6.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 6.4.4.3. Product Benchmarking
    • 6.4.4.4. Strategic Initiatives

List of Tables

• Table 1 List of abbreviations
• Table 2 U.S. External Counterpulsation (ECP) Devices Market, By Product, 2018 - 2030 (USD Million)
• Table 3 U.S. External Counterpulsation (ECP) Devices Market, By End-Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information procurement
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 Market formulation & validation
• Fig. 7 U.S. external counterpulsation (ECP) devices market segmentation
• Fig. 8 Market snapshot, 2022
• Fig. 9 Market trends & outlook
• Fig. 10 Market driver relevance analysis (current & future impact)
• Fig. 11 Market restraint relevance analysis (current & future impact)
• Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 13 Porter's five forces analysis
• Fig. 14 Market penetration & growth prospect mapping, 2022
• Fig. 15 U.S. External Counterpulsation (ECP) Devices Market: Product Movement Analysis
• Fig. 16 U.S. External Counterpulsation (ECP) Devices Market, For Pneumatic ECP Devices, 2018 - 2030 (USD Million)
• Fig. 17 U.S. External Counterpulsation (ECP) Devices Market, For Electrocardiogram (ECG)-Synchronized ECP Devices, 2018 - 2030 (USD Million)
• Fig. 18 U.S. External Counterpulsation (ECP) Devices Market, For Enhanced External Counterpulsation (EECP) Devices, 2018 - 2030 (USD Million)
• Fig. 19 U.S. External Counterpulsation (ECP) Devices Market: End-use Movement Analysis
• Fig. 20 U.S. External Counterpulsation (ECP) Devices Market, For Cardiac Centers, 2018 - 2030 (USD Million)
• Fig. 21 U.S. External Counterpulsation (ECP) Devices Market, For Hospitals, 2018 - 2030 (USD Million)